Tuberculosis Recurrence after Completion Treatment in a European City: Reinfection or Relapse?

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Millet, Juan Pablo ^a,b,c   Shaw, Evelyn ^a   Orcau, Àngels ^a,b   Casals, Martí ^a,b,d,e   Miró, Jose M ^f   Caylà, Joan A ^a,b   Vidal, Rafael ^g   Tórtola, Maria Teresa ^g   Martín, Nuria ^g   Martínez, José A ^f   González, Julià ^f   Tudó, Griselda ^f   Borrell, Sonia ^f   López Colomés, José L ^h   Sánchez, Francesca ^h   Salvadó, Margarita ^f   Sambeat, M Antonia ⁱ   Pomar, Virginia ⁱ   Coll, Pere ⁱ   March, Francesca ⁱ   Español, Montse ⁱ   Jiménez, M Ángeles ^j   Milà, Célia ^j   de Souza, M Luiza ^j   Clos, Roser ^a   Gorrindo, Pilar ^a   Nelson, Jeanne L ^a   more..

^a AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h HOSPITAL DEL MAR   (Spain)

ⁱ HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^j Unidad de Pre vención y Control de la Tuberculosis   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CITY; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; EUROPE; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; POPULATION RESEARCH; RECURRENCE RISK; RECURRENT INFECTION; REINFECTION; RELAPSE; RETROSPECTIVE STUDY; SPAIN; SURVIVAL; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; AGED; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPAIN; TUBERCULOSIS; YOUNG ADULT;

EID: 84878921853     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064898     Document Type: Article

References (35)

1. Bandera A, Gori A, Catozzi, Esposti AD, Marchetti G, Molteni C, et al. (2001) Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J Clin Microbiol. 39: 2213-18.
2. Jasmer RM, Bozeman L, Schwartzman K, (2004) Recurrent tuberculosis in the United States and Canada: relapse or reinfection?. Am J Respir Crit Care Med. 170: 1360-66.
3. Cacho J, Pérez-Meixeira A, Cano I, Soria T, Ramos-Martos A, Sánchez Concheiro M, et al. (2007) Recurrent tuberculosis from 1992 to 2004 in a metropolitan area. Eur Respir J. 30: 333-37.
4. Van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, et al. (1999) Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Eng J Med. 341: 1174-79.
5. Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P, (2001) HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 358: 1687-93.
6. Caminero JA, Pena MJ, Campos-Herrero MI, Rodriguez JC, Afonso O, Martin C, et al. (2001) Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am J Respir Crit Care Med. 163: 717-20.
7. García de Viedma D, Marín M, Hernangómez S, Diaz M, Ruiz-serrano MJ, Alcalá L, et al. (2002) Tuberculosis recurrences. Reinfection plays a role in a population whose clinical/epidemiological characteristics do not favor reinfection. Arch Intern Med. 162: 1873-79.
8. Millet JP, Orcau A, Garcia de Olalla P, Casals M, Rius C, Caylà JA, (2009) Tuberculosis recurrence and its associated risk factors among successfully treated patients. J Epidemiol Community Health. 63: 799-804.
9. Fine P, Small P, (1999) Exogenous reinfection in tuberculosis. N Engl J Med 16: 1226-28.
10. Orcau A, Rius C, Garcia de Olalla P, Caylà JA (2010) La tuberculosis a Barcelona. Informes 2003-2008. Barcelona: Publicaciones de la Agencia de Salud Pública,2003-2008. [Accessed June 6, 2010]. Available: http://www.aspb.cat/quefem/documents_tuberculosi.htm.
11. Població i demografía (2009) Anuari estadístic de la ciutat de Barcelona 2009. [Accessed June 6, 2010]. Available: http://www.bcn.cat/estadistica/catala/dades/anuari/pdf/capitol02.pdf).
12. World Health Organization (2003) Treatment of tuberculosis: Guidelines for national programmes. Geneva: World Health Organization. WHO/CDS/TB/2003.313.
13. National plan for the prevention and control of tuberculosis in Spain. (2009) Arch Bronconeumol. Mar; 45(3): 139-44. Epub 2009 Feb 28. Spanish. PubMed PMID: 19251347.
14. European Center for Disease Prevention and Control (ECDC) and WHO. (2012) Tuberculosis Surveillance and monitoring in Europe. Available at: http://ecdc.europa.eu/en/publications/Publications/1203-Annual-TB-Report.pdf.
15. Faustini A, Hall AJ, Perucci CA, (2091) Tuberculosis treatment outcomes in Europe: a systematic review. ERJ 2005 26: 503-10 doi: 10.1183/09031936.05.00103504.
16. CDC. Reported Tuberculosis in the United States (2009) Atlanta, GA: U.S. Department of Health and Human Services, CDC, October 2010. (Appendix B - Recommendations for Counting Reported Tuberculosis Cases). [Accessed March 13,2011]. Available: http://www.cdc.gov/tb/statistics/reports/2009/pdf/report2009.pdf.
17. Plan para la prevención y control de la tuberculosis en España Propuesta del Grupo de trabajo de expertos en tuberculosis y del Grupo de trabajo de Comunidades Autónomas (2008) Aceptada en Noviembre de 2007 por la Comisión de Salud Pública. [Accessed June 15, 2010]. Available: http://www.gencat.cat/salut/depsalut/html/ca/dir2095/tbcprevespa.pdf.
18. Pfyffer GE, Brown-Elliot BA, Wallace RJ (2003) Mycobacterium: general characteristics, isolation, and staining procedures. Manual of clinical microbiology, 8th ed. Washington DC: ASM Press. p. 532-560.
19. Supply PC, Allix S. Lesjean M (2006) Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J. Clin. Microbiol. 444498-4510.
20. Borrell S, Español M, Orcau A, Tudó G, March F, et al. (2009) Factors associated with differences between conventional contact tracing and molecular epidemiology in study of tuberculosis transmission and analysis in the city of Barcelona, Spain. J Clin Microbiol. 47: 198-204.
21. Supply PE, Mazars S. Lesjean V, Vincent B (2000) Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol. Microbiol. 36762-771.
22. Supply P, Allix C, Lesjean S, (2006) Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing of Mycobacterium tuberculosis. J. Clin. Microbiol. 44 (12): 4498-4510.
23. Van Embden JD, Cave MD, Crawford JT, et al. (1993) Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 31: 406-409.
24. Panjabi R, Comstock GW, Golub JE, (2007) Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis. 11: 828-37.
25. Crofts JP, Andrews NJ, Barker RD, Delpech V, Abubakar I, (2010) Risk factors for recurrent tuberculosis in England and Wales, 1998-2005. Thorax 65: 310-14.
26. Dobler CC, Crawford ABH, Jelfs PJ, Gilbert GL, Marks GB, (2009) Recurrence of tuberculosis in a low incidence setting. Eur Respir J 33: 160-7.
27. Shen G, Xue Z, Shen X, Sun B, Gui X, Shen M, et al. (2006) Recurrent tuberculosis and exogenous reinfection, Shangai, China. Emerg Infect Dis. 12: 1176-8.
28. Verver S, Warren RM, Beyers N, Richardson M, et al. (2005) Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med. 171: 1430-35.
29. Charalambous S, Grant AD, Moloi V, Warren R, Day JH, Van Helden P, et al. (2008) Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int J Tuberc Lung Dis. 12: 942-48.
30. Pettit AC, Kaltenbach LA, Maruri F, (2011) Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting. Int J Tuberc Lung Dis. Jul 15(7): 906-11.
31. Narayanan S, Swaminathan S, Supply P, Shanmugam S, (2001) Impact of HIV infection on the recurrence of tuberculosis in South India. J Infect Dis. 2010 Mar (5): 691-703.
32. Millet JP, Orcau A, Casals M, Garcia de Olalla P, Caylà JA, (2013) Recurrences in tuberculosis in a cohort of human immunodeficiency virus-infected patients: The influence of highly active antiretroviral therapy. Enferm Infecc Microbiol Clin. Apr 31(4): 227-9.
33. Kim L, Moonan PK, Yelk Woodruff RS, Kammerer JS, Haddad MB, (2013) Epidemiology of recurrent tuberculosis in the United States, 1993-2010. Int J Tuberc Lung Dis. Mar 17(3): 357-60.
34. Bang D, Andersen AB, Thomsen VO, Lillebaek T, (2010) Recurrent tuberculosis in Denmark: relapse vs. re-infection. Int J Tuberc Lung Dis. 14: 447-53.
35. Ospina JE, Orcau A, Millet JP, Sánchez F, Casals M, Rius C, Caylà JA, (2012) Improving contact tracing in tuberculosis effectiveness of community health workers in a city with massive recent immigration. BMC Public Health 12: 158.